Dare Bioscience, Inc. (DARE)

NASDAQ: DARE · IEX Real-Time Price · USD
1.19
-0.03 (-2.46%)
Aug 17, 2022 4:00 PM EDT - Market closed

Cash Flow Statement (Quarterly)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ended 2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Net Income
0.41-8.4-9.54-12.67-9.16-7.32-8.44-7.58-7.12-4.25-3.87-3.39-3.95-3.05-2.92-2.57-3.58-7.67-9.13-1.63-0.5-0.24-0.2-0.02-10.86-13.54-10.71-10.55-9.91-8.43-7.47-5.56-7.4-2.91-3.48-3.2-4.89-5.57
Depreciation & Amortization
0.03-0-0.02-0.02-0.01-0.02-0.03-0.02-0.02-0.04-0-0.02000.0100000000-0.130.070.060.060.050.040.040.030.030.030.040.030.040.050.07
Share-Based Compensation
0.540.530.390.440.410.370.20.190.190.160.120.140.110.10.080.040.010.010.010.01000.01-1.460.720.740.640.840.460.440.260.290.20.150.130.050.290.15
Other Operating Activities
-9.43-4.47-0.7413.57-3.02-1.4-0.922.052.87-2.46-0.060.10.82-0.360.11-0.220.885.548.160.20.390.190.0225.9-1.16-0.521.791.71.610.011.57-0.322.95-0.940.04-0.11-0.970.75
Operating Cash Flow
-8.45-12.34-9.921.32-11.79-8.38-9.19-5.36-4.09-6.6-3.81-3.18-3.02-3.31-2.71-2.75-2.69-2.12-0.96-1.42-0.11-0.05-0.1724.3-11.24-13.26-8.21-7.97-7.8-7.94-5.61-5.56-4.23-3.67-3.27-3.22-5.52-4.6
Capital Expenditures
-0-00-0.0100-000000000-00000-1.5000.47-0.11-0.36-0.11-0.03-0.08-0.03-0.11-0.080.01-00-0-0-0
Acquisitions
00000000006.140000-0.060009.92000000000000000000
Other Investing Activities
00000000000000000000000-0.1200.1200-0.23000000000
Investing Cash Flow
-0-00-0.0100-00006.140000-0.060009.92-1.5000.36-0.11-0.24-0.11-0.03-0.31-0.03-0.11-0.080.01-00-0-0-0
Share Issuance / Repurchase
1.3401635.2213.2511.378.455.44.026.89005.150-0-0.08-010.200000-0.0400.0400.1637.252.4100.0159.970.030.02000.02
Debt Issued / Paid
000000000.37000000000000.060.10.23.9-1.97-1.936.60010.72-0.9-0.86-1.017.69-1.178.05-0.76-0.75
Other Financing Activities
00000000000000000000000000000.02-0.02001.07-1.070000
Financing Cash Flow
1.3401635.2213.2511.378.455.44.396.89005.150-0-0.08-010.2000.060.10.23.86-1.97-1.896.60.1637.2713.11-0.9-0.8560.036.65-1.158.05-0.76-0.73
Net Cash Flow
-7.25-12.366.136.461.452.99-0.720.040.30.272.34-3.22.13-3.3-2.73-2.91-3.188.07-0.978.49-0.050.050.0328.51-13.32-15.39-1.72-7.8529.165.14-6.61-6.4955.82.98-4.424.82-6.29-5.34
Free Cash Flow
-8.45-12.35-9.921.31-11.79-8.38-9.2-5.36-4.09-6.6-3.81-3.18-3.02-3.31-2.71-2.75-2.69-2.12-0.96-1.42-1.61-0.05-0.1724.77-11.35-13.62-8.32-8-7.88-7.97-5.72-5.64-4.22-3.67-3.27-3.22-5.52-4.6
Free Cash Flow Margin
-84.50%--------------------------------12797.00%-7808.50%-54516.70%---
Free Cash Flow Per Share
-0.10-0.15-0.190.02-0.23-0.19-0.31-0.17-0.15-0.28-0.21-0.19-0.19-0.29-0.24-0.24-0.23-0.24-0.30-0.28-1.77-0.06-0.1930.20-4.15-4.98-3.04-2.93-2.95-3.92-3.93-2.80-2.50-46.63-41.85-44.32-89.87-75.13
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).